Quick Answer
XERIANT, INC. reported Total Revenue of $79.7 thousand for fiscal year 2018.
XERIANT, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$1.65M +46.9% |
-$3.10M +56.3% |
-$7.10M +46.6% |
-$13.30M -392.2% |
-$2.70M -286.3% |
-$699.6K -725.4% |
| Diluted EPS | $0.00 +100.0% |
-$0.01 | — | — | — | — |
| Total Assets | $68.2K -90.4% |
$713.0K +326.6% |
$167.1K -86.8% |
$1.27M +10.8% |
$1.15M +342.5% |
$258.9K +8447.3% |
| Cash and Equivalents | — | — | — | — | $962.5K +2374.8% |
$38.9K +1184.0% |
| Stockholders Equity | -$5.82M -1.2% |
-$5.75M -51.7% |
-$3.79M -2211.4% |
-$164.1K -117.8% |
$922.0K +3052.8% |
-$31.2K +7.8% |
| R&D Expense | $69.3K -64.7% |
$196.4K | $0.00 -100.0% |
$5.27M +1311.8% |
$373.1K +5751.8% |
$6.4K -24.0% |
| Operating Income | -$1.37M +28.4% |
-$1.91M +7.1% |
-$2.05M +81.4% |
-$11.01M -400.7% |
-$2.20M -506.3% |
-$362.7K -329.9% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 695.75M +32.6% |
524.85M +34.8% |
389.43M +6.6% |
365.24M +24.7% |
292.82M +320.8% |
69.58M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2018 | $375.00 | -99.7% | -99.5% |
| Net Income | December 31, 2025 | -$297.6K | +28.7% | -113.4% |
| Diluted EPS | December 31, 2025 | $0.00 | — | — |
| Total Assets | December 31, 2025 | $103.4K | -62.6% | +44.2% |
| Cash and Equivalents | March 31, 2022 | $1.69M | +12.4% | -19.8% |
| Stockholders Equity | December 31, 2025 | -$2.76M | +52.5% | +2.3% |
| R&D Expense | December 31, 2025 | $16.3K | +108586.7% | -69.8% |
| Operating Income | December 31, 2025 | -$231.1K | +31.1% | +24.0% |
| Gross Profit | March 31, 2018 | $375.00 | -99.7% | -99.4% |
| Shares Outstanding | December 31, 2025 | 862.76M | +1322.8% | +15.2% |
- XERIANT, INC. reported Total Revenue of $79.7 thousand for fiscal year 2018.
- XERIANT, INC. showed a decrease of -87.4% in Total Revenue compared to the prior fiscal year.
- XERIANT, INC. reported Net Income of -$1.65 million for fiscal year 2025.
- XERIANT, INC. showed an increase of +46.9% in Net Income compared to the prior fiscal year.
- XERIANT, INC. reported Diluted EPS of $0.00 per share for fiscal year 2025.
- XERIANT, INC. showed an increase of +100.0% in Diluted EPS compared to the prior fiscal year.
- XERIANT, INC. reported Total Assets of $68.2 thousand for fiscal year 2025.
- XERIANT, INC. showed a decrease of -90.4% in Total Assets compared to the prior fiscal year.
- XERIANT, INC. reported Cash and Equivalents of $962.5 thousand for fiscal year 2021.
- XERIANT, INC. showed an increase of +2374.8% in Cash and Equivalents compared to the prior fiscal year.
- XERIANT, INC. reported Stockholders Equity of -$5.82 million for fiscal year 2025.
- XERIANT, INC. showed a decrease of -1.2% in Stockholders Equity compared to the prior fiscal year.
- XERIANT, INC. reported R&D Expense of $69.3 thousand for fiscal year 2025.
- XERIANT, INC. showed a decrease of -64.7% in R&D Expense compared to the prior fiscal year.
- XERIANT, INC. reported Operating Income of -$1.37 million for fiscal year 2025.
- XERIANT, INC. showed an increase of +28.4% in Operating Income compared to the prior fiscal year.
- XERIANT, INC. reported Gross Profit of $57.5 thousand for fiscal year 2018.
- XERIANT, INC. showed a decrease of -86.8% in Gross Profit compared to the prior fiscal year.
- XERIANT, INC. reported Shares Outstanding of 695.75 million shares for fiscal year 2025.
- XERIANT, INC. showed an increase of +32.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: